Curriculum for pharmacology in pharmacy institutions in India: opportunities and challenges
The curriculum of pharmacy institutions in India is regulated by the All India Council for Technical Education (AICTE) and the Pharmacy Council of India (PCI) at degree and diploma levels. However, it has been over two decades that the syllabi have been revised by these regulatory agencies. Consider...
Gespeichert in:
Veröffentlicht in: | Indian journal of pharmacology 2014-05, Vol.46 (3), p.241-245 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 245 |
---|---|
container_issue | 3 |
container_start_page | 241 |
container_title | Indian journal of pharmacology |
container_volume | 46 |
creator | Goyal, Ramesh K Bhise, Satish B Srinivasan, B P Rao, C Mallikarjun Sen, Tuhinadri Koneri, Raju |
description | The curriculum of pharmacy institutions in India is regulated by the All India Council for Technical Education (AICTE) and the Pharmacy Council of India (PCI) at degree and diploma levels. However, it has been over two decades that the syllabi have been revised by these regulatory agencies. Considering the dynamic character of pharmacology, it is essential to prepare a syllabus that caters to the contemporary needs of the academic institutions and pharmaceutical industry, the community. Pharmacists are also witnessing a greater role in community pharmacy practice as well as in several healthcare sectors. Considering these facts, a panel discussion was held at IPSCON 2013, (the Annual Conference of Indian Pharmacological Society) at Bangalore. The discussion saw several recommendations for syllabi for institutions offering various pharmacy courses to meet the objectives of teaching, learning and research in Pharmacology. This article documents a summary of the discussion. For B. Pharm. course, a balance between industry-oriented pharmacology and clinical pharmacy has been recommended. Redundant animal experiments should be replaced with the simulation experiments or those which are feasible in the light of stringent regulations of the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA). It is recommended that the M. Pharm curriculum should focus on preclinical research with the inclusion of molecular biology and experiments on gene expression, proteomics, pharmacogenomics, cell culture and tissue culture. In general, at all levels, exposure of students to hospitals and clinicians is needed. Pharm. D., syllabus too should lay lesser emphasis on experimental pharmacology. Present experiments in the D. Pharm. course have no relevance to the program objectives and hence, only experiments through demonstrations or simulated preparations or interactive videos maybe undertaken. Regulatory bodies as well as universities should design a comprehensive syllabus and plan an effective pedagogy to prepare graduates who are competent and capable of bringing positive changes in the community and healthcare in India. |
doi_str_mv | 10.4103/0253-7613.132149 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4071697</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A368883957</galeid><sourcerecordid>A368883957</sourcerecordid><originalsourceid>FETCH-LOGICAL-c529t-d2f0bad1438c0de438ba4850f34f3ae9734205fc9671b4f8c568278506eb806d3</originalsourceid><addsrcrecordid>eNptUk1v1DAQtRCIbhfunFAkLlyy2PFHbA5I1YpCpUpc4MTBchw76yqxgx0j9d_jaNuFotUcxuN57409egC8QXBHEMQfYENx3TKEdwg3iIhnYIOE4DVuKXoONqf2BbhM6Q6Wmgj2Elw0RPAWsXYDfu5zjE7nMU-VDbGaDypOSocxDPeV84_1ek6LW_Ligk9r48b3Tn2swjyHuGTvFmdSpXxf6YMaR-MHk16BF1aNybx-yFvw4_rz9_3X-vbbl5v91W2taSOWum8s7FSPCOYa9qakThFOocXEYmVEi0kDqdWCtagjlmvKeNMWADMdh6zHW_DpqDvnbjK9Nn6JapRzdJOK9zIoJ592vDvIIfyWBJYlFP0teP8gEMOvbNIiJ5e0GUflTchJIkoaRkSJAn33H_Qu5OjL9woKE4RbQcVf1KBGI523oczVq6i8woxzjgVdx9ZnUIPxpjwyeGNduX6C353Bl-jN5PRZAjwSdAwpRWNPO0FQrgaSq0Pk6hB5NFChvP13lyfCo2PwHzPUwA0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1534137959</pqid></control><display><type>article</type><title>Curriculum for pharmacology in pharmacy institutions in India: opportunities and challenges</title><source>MEDLINE</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Goyal, Ramesh K ; Bhise, Satish B ; Srinivasan, B P ; Rao, C Mallikarjun ; Sen, Tuhinadri ; Koneri, Raju</creator><creatorcontrib>Goyal, Ramesh K ; Bhise, Satish B ; Srinivasan, B P ; Rao, C Mallikarjun ; Sen, Tuhinadri ; Koneri, Raju</creatorcontrib><description>The curriculum of pharmacy institutions in India is regulated by the All India Council for Technical Education (AICTE) and the Pharmacy Council of India (PCI) at degree and diploma levels. However, it has been over two decades that the syllabi have been revised by these regulatory agencies. Considering the dynamic character of pharmacology, it is essential to prepare a syllabus that caters to the contemporary needs of the academic institutions and pharmaceutical industry, the community. Pharmacists are also witnessing a greater role in community pharmacy practice as well as in several healthcare sectors. Considering these facts, a panel discussion was held at IPSCON 2013, (the Annual Conference of Indian Pharmacological Society) at Bangalore. The discussion saw several recommendations for syllabi for institutions offering various pharmacy courses to meet the objectives of teaching, learning and research in Pharmacology. This article documents a summary of the discussion. For B. Pharm. course, a balance between industry-oriented pharmacology and clinical pharmacy has been recommended. Redundant animal experiments should be replaced with the simulation experiments or those which are feasible in the light of stringent regulations of the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA). It is recommended that the M. Pharm curriculum should focus on preclinical research with the inclusion of molecular biology and experiments on gene expression, proteomics, pharmacogenomics, cell culture and tissue culture. In general, at all levels, exposure of students to hospitals and clinicians is needed. Pharm. D., syllabus too should lay lesser emphasis on experimental pharmacology. Present experiments in the D. Pharm. course have no relevance to the program objectives and hence, only experiments through demonstrations or simulated preparations or interactive videos maybe undertaken. Regulatory bodies as well as universities should design a comprehensive syllabus and plan an effective pedagogy to prepare graduates who are competent and capable of bringing positive changes in the community and healthcare in India.</description><identifier>ISSN: 0253-7613</identifier><identifier>EISSN: 1998-3751</identifier><identifier>DOI: 10.4103/0253-7613.132149</identifier><identifier>PMID: 24987167</identifier><language>eng</language><publisher>India: Medknow Publications and Media Pvt. Ltd</publisher><subject>Curriculum ; Curriculum development ; Education ; Education Forum ; Humans ; India ; Pharmaceutical sciences ; Pharmacists ; Pharmacology - education ; Pharmacy ; Schools, Pharmacy ; Study and teaching ; Teaching</subject><ispartof>Indian journal of pharmacology, 2014-05, Vol.46 (3), p.241-245</ispartof><rights>COPYRIGHT 2014 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications & Media Pvt Ltd Jun 2014</rights><rights>Copyright: © Indian Journal of Pharmacology 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c529t-d2f0bad1438c0de438ba4850f34f3ae9734205fc9671b4f8c568278506eb806d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071697/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071697/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24987167$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Goyal, Ramesh K</creatorcontrib><creatorcontrib>Bhise, Satish B</creatorcontrib><creatorcontrib>Srinivasan, B P</creatorcontrib><creatorcontrib>Rao, C Mallikarjun</creatorcontrib><creatorcontrib>Sen, Tuhinadri</creatorcontrib><creatorcontrib>Koneri, Raju</creatorcontrib><title>Curriculum for pharmacology in pharmacy institutions in India: opportunities and challenges</title><title>Indian journal of pharmacology</title><addtitle>Indian J Pharmacol</addtitle><description>The curriculum of pharmacy institutions in India is regulated by the All India Council for Technical Education (AICTE) and the Pharmacy Council of India (PCI) at degree and diploma levels. However, it has been over two decades that the syllabi have been revised by these regulatory agencies. Considering the dynamic character of pharmacology, it is essential to prepare a syllabus that caters to the contemporary needs of the academic institutions and pharmaceutical industry, the community. Pharmacists are also witnessing a greater role in community pharmacy practice as well as in several healthcare sectors. Considering these facts, a panel discussion was held at IPSCON 2013, (the Annual Conference of Indian Pharmacological Society) at Bangalore. The discussion saw several recommendations for syllabi for institutions offering various pharmacy courses to meet the objectives of teaching, learning and research in Pharmacology. This article documents a summary of the discussion. For B. Pharm. course, a balance between industry-oriented pharmacology and clinical pharmacy has been recommended. Redundant animal experiments should be replaced with the simulation experiments or those which are feasible in the light of stringent regulations of the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA). It is recommended that the M. Pharm curriculum should focus on preclinical research with the inclusion of molecular biology and experiments on gene expression, proteomics, pharmacogenomics, cell culture and tissue culture. In general, at all levels, exposure of students to hospitals and clinicians is needed. Pharm. D., syllabus too should lay lesser emphasis on experimental pharmacology. Present experiments in the D. Pharm. course have no relevance to the program objectives and hence, only experiments through demonstrations or simulated preparations or interactive videos maybe undertaken. Regulatory bodies as well as universities should design a comprehensive syllabus and plan an effective pedagogy to prepare graduates who are competent and capable of bringing positive changes in the community and healthcare in India.</description><subject>Curriculum</subject><subject>Curriculum development</subject><subject>Education</subject><subject>Education Forum</subject><subject>Humans</subject><subject>India</subject><subject>Pharmaceutical sciences</subject><subject>Pharmacists</subject><subject>Pharmacology - education</subject><subject>Pharmacy</subject><subject>Schools, Pharmacy</subject><subject>Study and teaching</subject><subject>Teaching</subject><issn>0253-7613</issn><issn>1998-3751</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptUk1v1DAQtRCIbhfunFAkLlyy2PFHbA5I1YpCpUpc4MTBchw76yqxgx0j9d_jaNuFotUcxuN57409egC8QXBHEMQfYENx3TKEdwg3iIhnYIOE4DVuKXoONqf2BbhM6Q6Wmgj2Elw0RPAWsXYDfu5zjE7nMU-VDbGaDypOSocxDPeV84_1ek6LW_Ligk9r48b3Tn2swjyHuGTvFmdSpXxf6YMaR-MHk16BF1aNybx-yFvw4_rz9_3X-vbbl5v91W2taSOWum8s7FSPCOYa9qakThFOocXEYmVEi0kDqdWCtagjlmvKeNMWADMdh6zHW_DpqDvnbjK9Nn6JapRzdJOK9zIoJ592vDvIIfyWBJYlFP0teP8gEMOvbNIiJ5e0GUflTchJIkoaRkSJAn33H_Qu5OjL9woKE4RbQcVf1KBGI523oczVq6i8woxzjgVdx9ZnUIPxpjwyeGNduX6C353Bl-jN5PRZAjwSdAwpRWNPO0FQrgaSq0Pk6hB5NFChvP13lyfCo2PwHzPUwA0</recordid><startdate>20140501</startdate><enddate>20140501</enddate><creator>Goyal, Ramesh K</creator><creator>Bhise, Satish B</creator><creator>Srinivasan, B P</creator><creator>Rao, C Mallikarjun</creator><creator>Sen, Tuhinadri</creator><creator>Koneri, Raju</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications & Media Pvt. Ltd</general><general>Medknow Publications & Media Pvt Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20140501</creationdate><title>Curriculum for pharmacology in pharmacy institutions in India: opportunities and challenges</title><author>Goyal, Ramesh K ; Bhise, Satish B ; Srinivasan, B P ; Rao, C Mallikarjun ; Sen, Tuhinadri ; Koneri, Raju</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c529t-d2f0bad1438c0de438ba4850f34f3ae9734205fc9671b4f8c568278506eb806d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Curriculum</topic><topic>Curriculum development</topic><topic>Education</topic><topic>Education Forum</topic><topic>Humans</topic><topic>India</topic><topic>Pharmaceutical sciences</topic><topic>Pharmacists</topic><topic>Pharmacology - education</topic><topic>Pharmacy</topic><topic>Schools, Pharmacy</topic><topic>Study and teaching</topic><topic>Teaching</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Goyal, Ramesh K</creatorcontrib><creatorcontrib>Bhise, Satish B</creatorcontrib><creatorcontrib>Srinivasan, B P</creatorcontrib><creatorcontrib>Rao, C Mallikarjun</creatorcontrib><creatorcontrib>Sen, Tuhinadri</creatorcontrib><creatorcontrib>Koneri, Raju</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Indian journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Goyal, Ramesh K</au><au>Bhise, Satish B</au><au>Srinivasan, B P</au><au>Rao, C Mallikarjun</au><au>Sen, Tuhinadri</au><au>Koneri, Raju</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Curriculum for pharmacology in pharmacy institutions in India: opportunities and challenges</atitle><jtitle>Indian journal of pharmacology</jtitle><addtitle>Indian J Pharmacol</addtitle><date>2014-05-01</date><risdate>2014</risdate><volume>46</volume><issue>3</issue><spage>241</spage><epage>245</epage><pages>241-245</pages><issn>0253-7613</issn><eissn>1998-3751</eissn><abstract>The curriculum of pharmacy institutions in India is regulated by the All India Council for Technical Education (AICTE) and the Pharmacy Council of India (PCI) at degree and diploma levels. However, it has been over two decades that the syllabi have been revised by these regulatory agencies. Considering the dynamic character of pharmacology, it is essential to prepare a syllabus that caters to the contemporary needs of the academic institutions and pharmaceutical industry, the community. Pharmacists are also witnessing a greater role in community pharmacy practice as well as in several healthcare sectors. Considering these facts, a panel discussion was held at IPSCON 2013, (the Annual Conference of Indian Pharmacological Society) at Bangalore. The discussion saw several recommendations for syllabi for institutions offering various pharmacy courses to meet the objectives of teaching, learning and research in Pharmacology. This article documents a summary of the discussion. For B. Pharm. course, a balance between industry-oriented pharmacology and clinical pharmacy has been recommended. Redundant animal experiments should be replaced with the simulation experiments or those which are feasible in the light of stringent regulations of the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA). It is recommended that the M. Pharm curriculum should focus on preclinical research with the inclusion of molecular biology and experiments on gene expression, proteomics, pharmacogenomics, cell culture and tissue culture. In general, at all levels, exposure of students to hospitals and clinicians is needed. Pharm. D., syllabus too should lay lesser emphasis on experimental pharmacology. Present experiments in the D. Pharm. course have no relevance to the program objectives and hence, only experiments through demonstrations or simulated preparations or interactive videos maybe undertaken. Regulatory bodies as well as universities should design a comprehensive syllabus and plan an effective pedagogy to prepare graduates who are competent and capable of bringing positive changes in the community and healthcare in India.</abstract><cop>India</cop><pub>Medknow Publications and Media Pvt. Ltd</pub><pmid>24987167</pmid><doi>10.4103/0253-7613.132149</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0253-7613 |
ispartof | Indian journal of pharmacology, 2014-05, Vol.46 (3), p.241-245 |
issn | 0253-7613 1998-3751 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4071697 |
source | MEDLINE; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry |
subjects | Curriculum Curriculum development Education Education Forum Humans India Pharmaceutical sciences Pharmacists Pharmacology - education Pharmacy Schools, Pharmacy Study and teaching Teaching |
title | Curriculum for pharmacology in pharmacy institutions in India: opportunities and challenges |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T15%3A19%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Curriculum%20for%20pharmacology%20in%20pharmacy%20institutions%20in%20India:%20opportunities%20and%20challenges&rft.jtitle=Indian%20journal%20of%20pharmacology&rft.au=Goyal,%20Ramesh%20K&rft.date=2014-05-01&rft.volume=46&rft.issue=3&rft.spage=241&rft.epage=245&rft.pages=241-245&rft.issn=0253-7613&rft.eissn=1998-3751&rft_id=info:doi/10.4103/0253-7613.132149&rft_dat=%3Cgale_pubme%3EA368883957%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1534137959&rft_id=info:pmid/24987167&rft_galeid=A368883957&rfr_iscdi=true |